亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應CAS號: 58-93-5氫氯噻嗪原料
廠家供應CAS號: 58-93-5氫氯噻嗪原料
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 58-93-5
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:01
 
詳細信息
廠家供應CAS號: 58-93-5氫氯噻嗪原料
氫氯噻嗪

中文名稱: 雙氫氯噻嗪
中文同義詞: 雙氫氯噻嗪;氫氯噻嗪;雙氫克尿噻;雙氫氯噻秦;雙氫氯消痰;6-氯-3,4-二氫-2H-1,2,4-苯并噻二嗪-7-磺酰胺-1,1-二氧化物;雙氫克尿塞/二氫氯噻;二氫氯噻
英文名稱: Hydrochlorothiazide
英文同義詞: 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide;2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-,1,1-dioxide;3,4-Dihydro-6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide;6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide;6-Chloro-3,4-dihydro-7-sulphamoyl-1,2,4-ben-zoth-iadi-azine1,1-dioxcide;6-chloro-7-sulfamoyl-3,4-dihydro-2h-1,2,4-benzothiadiazine;6-Chloro-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide;6-chloro-7-sulfamoyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide
CAS號: 58-93-5
分子式: C7H8ClN3O4S2
分子量: 297.74
EINECS號: 200-403-3
包裝: 25kg紙板桶
含量:99%
質量標準:BP2009 usp31
性狀: 白色結晶性粉末。溶點273-275℃,溶于***,微溶于醇,不溶于水、氯仿、**,溶于氫氧化鈉溶液,但易水解。味微苦 
制備: 由間氯苯胺經氯磺化得到5-氯-2,4-氯磺酰苯胺,再氨反應生成5-氯-2,4-氨磺苯胺,最后用甲醛歪合制得 
主要用途: 用作利尿藥,可降低血壓,有利尿作用,常與其他降壓藥合并使用。

Hydrochlorothiazide 99.0% BP2009;usp31
Product name: Hydrochlorothiazide
CAS No.: 58-93-5
Assay: 99.0%
Packing: 25kg/drum
M.F.: C7H8ClN3O4S2
M.W.: 297.74
Reference Standard: BP2009;usp31
Appearance: White crystalline powder
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28732  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |